Jun Fei Feng
Director of Finance/CFO at Beijing Shenogen Pharma Group Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kun Meng | M | 61 |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 18 years |
| Zhao Yi Wang | M | 65 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 18 years |
| Larry Zhang | M | - |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Xu Tian | F | 64 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Shu Xue Wang | M | 48 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 9 years |
| Jun Xie | M | 55 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Lei Zhu | F | 44 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 10 years |
| Yan Min Tang | F | 51 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Jian Guang Li | M | 59 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Bao Ping Wang | M | 63 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 6 years |
| Yong Peng | M | 62 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 6 years |
| Jian Xun Liu | M | 69 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Ye Yan | F | 66 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Wing Yu Leung | F | 53 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Meng Jun Xue | M | 53 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| San Guo Zhu | M | 74 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 8 years |
| Su Zhang | M | 49 |
Central University of Finance & Economics
| 17 years |
| Bing Wu | M | 50 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Lei Chen | M | 45 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Daqing Cai | M | 59 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
| Gui Hua Lu | M | 56 |
Central University of Finance & Economics
| 17 years |
| Jun Feng Wang | M | 50 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 5 years |
| Robert Eisenman | M | - |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jun Bao | M | 58 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 6 years |
| Hong Lian Gong | M | 40 |
Central University of Finance & Economics
| 6 years |
| Na Sun | M | 46 |
Central University of Finance & Economics
| 13 years |
| Ping Lin He | M | 47 |
Central University of Finance & Economics
| 3 years |
| Hao Guo | M | 45 |
Northwest University of Politics & Law
| 3 years |
| Xue Jun Jin | M | 44 |
Central University of Finance & Economics
| 1 years |
| Qi Lu | M | 43 |
Central University of Finance & Economics
| 2 years |
| Runsheng Chi | M | 36 |
Central University of Finance & Economics
| 4 years |
| Zhi Shan Shi | M | 46 |
Central University of Finance & Economics
| 4 years |
| Shimeng Lin | M | 35 |
Central University of Finance & Economics
| 4 years |
| Jun Li | M | 51 |
Central University of Finance & Economics
| 1 years |
| Yu Li Meng | F | 46 |
Central University of Finance & Economics
| 1 years |
| Yun Xiang Zhu | M | 60 |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | 2 years |
| Si Cai | M | 44 |
Northwest University of Politics & Law
| 3 years |
| Han Mei Huang | F | 43 |
Central University of Finance & Economics
| 1 years |
| Zhi Qiang Su | M | 41 |
Central University of Finance & Economics
| 1 years |
| Wei Yuan | F | 50 |
Central University of Finance & Economics
| 3 years |
| Rui Xu | F | 40 |
Central University of Finance & Economics
| 4 years |
| Yuli Liu | M | 42 |
Northwest University of Politics & Law
| 3 years |
| Xiaojie Qiao | F | 51 |
Central University of Finance & Economics
| 1 years |
| Xiao Jie Liu | F | 40 |
Central University of Finance & Economics
| 4 years |
| Si Liang Wu | M | 40 |
Central University of Finance & Economics
| 1 years |
| Li Ye Peng | M | 57 |
Central University of Finance & Economics
| 2 years |
| Zheng Yang Tan | M | 45 |
Central University of Finance & Economics
| 1 years |
| Dingyi Yu | M | 45 |
Central University of Finance & Economics
| 1 years |
| He Yang | M | 43 |
Central University of Finance & Economics
| 1 years |
| Hao Di | M | 47 |
Central University of Finance & Economics
| 2 years |
| Xiao Jie Chong | F | 47 |
Central University of Finance & Economics
| 1 years |
| Zhan Qiang Zhang | M | 57 |
Central University of Finance & Economics
| 4 years |
| Liye Zhou | M | 50 |
Central University of Finance & Economics
| 3 years |
| Xian Ni | M | 38 |
Northwest University of Politics & Law
| 4 years |
| Junwei Zou | M | 39 |
Central University of Finance & Economics
| 3 years |
| Jing Jin | F | 38 |
Central University of Finance & Economics
| 4 years |
| Jun Ma | M | 45 |
Northwest University of Politics & Law
| 3 years |
| Bo Shi | F | 45 |
Central University of Finance & Economics
| 1 years |
| Wen Bing Wang | M | 50 |
Central University of Finance & Economics
| 1 years |
| Cheng Wei Liu | M | 47 |
Northwest University of Politics & Law
| 3 years |
| Yu Han | F | 52 |
Central University of Finance & Economics
| 1 years |
| Hui Wu | M | 42 |
Central University of Finance & Economics
| 4 years |
| Guang Lei Chen | M | 54 |
Central University of Finance & Economics
| 3 years |
| Jin Zheng | F | 42 |
Central University of Finance & Economics
| 1 years |
| Jun Xi Jack Zhang | M | 60 |
Central University of Finance & Economics
| 3 years |
| Yan Su Hao | M | 66 |
Central University of Finance & Economics
| - |
| Feng Li Wang | F | 61 |
Northwest University of Politics & Law
| 3 years |
| Yue Xiang Wang | M | 56 |
Central University of Finance & Economics
| 3 years |
| Hua Zhao | F | - |
Central University of Finance & Economics
| 4 years |
| Zhi Cheng Wang | M | 50 |
Central University of Finance & Economics
| 4 years |
| Lina Liu | F | 45 |
Central University of Finance & Economics
| 1 years |
| Yi Zhou | F | 42 |
Central University of Finance & Economics
| 1 years |
| Jinwen Chen | M | - |
Central University of Finance & Economics
| 4 years |
| Yi Fan Song | F | 47 |
Central University of Finance & Economics
| 2 years |
| Hai Ying Zheng | M | 61 |
Central University of Finance & Economics
| 3 years |
| Yang Mu | M | 48 |
Central University of Finance & Economics
| 2 years |
| Xing Bo Gao | M | 60 |
Central University of Finance & Economics
| 3 years |
| Li Yu | M | 53 |
Central University of Finance & Economics
| 3 years |
| Lan Nan Wu | F | 43 |
Central University of Finance & Economics
| 4 years |
| Amber Yang | F | - |
Central University of Finance & Economics
| 4 years |
| Yang Zhang | M | - |
Central University of Finance & Economics
| 4 years |
| Rui Qin Guo | F | 49 |
Central University of Finance & Economics
| 2 years |
| Pang Zhang | F | 36 |
Central University of Finance & Economics
| 4 years |
| Xiangmei Liu | F | 42 |
Central University of Finance & Economics
| 3 years |
| Rong Sheng Bu | M | 35 |
Central University of Finance & Economics
| 4 years |
| Benjamin Duan | M | 38 |
Central University of Finance & Economics
| 4 years |
| Man Li Cai | F | 51 |
Central University of Finance & Economics
| 1 years |
| Zhao Yue Zhang | M | 34 |
Central University of Finance & Economics
| 4 years |
| Fang Qiang Meng | M | 46 |
Central University of Finance & Economics
| 3 years |
| Zhi Shan Shi | M | 46 |
Central University of Finance & Economics
| 2 years |
| Zhao Fei Yu | M | - |
Northwest University of Politics & Law
| 3 years |
| Pei Zhao He | M | 35 |
Central University of Finance & Economics
| 4 years |
| Yao Wang | M | 49 |
Central University of Finance & Economics
| 3 years |
| Jia You | M | 46 |
Northwest University of Politics & Law
| 3 years |
| Xin Jiang Wang | M | 58 |
Central University of Finance & Economics
| 1 years |
| He Hui Lu | F | 46 |
Central University of Finance & Economics
| 4 years |
| Jun Chen | M | 46 |
Northwest University of Politics & Law
| 3 years |
| Yuan Yuan Zhao | F | - |
Northwest University of Politics & Law
| 3 years |
| Jin Fu Ye | M | 49 |
Central University of Finance & Economics
| 1 years |
| Hanmei Huang | M | - |
Central University of Finance & Economics
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jun Fei Feng
- Personal Network
